secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001628280-25-050406
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Q3 record revenue $11.5M (+22% YoY); guides Q4 $13-14M
---------------------------------------------------------------

- Revenue of $11.5M, up 22% YoY and 13% sequentially; highest quarterly revenue in company history.
- GAAP operating income $1.5M vs $2.0M YoY, impacted by $1.4M stock-based compensation (none in Q3 2024).
- Net income $10.3M vs net loss of $20.7M YoY, driven by $6.1M non-cash derivative gain and $5.0M patent sale.
- Adjusted EBITDA grew to $3.5M from $2.1M YoY.
- Q4 2025 revenue guidance $13-14M; full-year FY2025 revenue guidance $44-45M (35-39% growth over FY2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025050406/0001628280-25-050406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025050406/snwv-20251107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-050406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer